Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.60 |
| ▸ | IDO1 | P14902 | 2/20 | 0.60 |
| ▸ | AGXT | P21549 | 2/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.56 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.56 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.56 |
| ▸ | CMA1 | P23946 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | LPO | P22079 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29587500 | 1.00 | TAAR1 (0.60) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| Cyclopropane SCHEMBL28787876 | 0.94 | TAAR1 (0.55) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL25980403 | 0.92 | TAAR1 (0.53) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL8785364 | 0.92 | TAAR1 (0.53) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL29092780 | 0.91 | ACHE (0.68) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL4937029 | 0.88 | FYN (0.56) | TAAR1IDO1AGXTMAOBSIGMAR1 | |
| SCHEMBL1956803 | 0.88 | KMT2A (0.55) | TAAR1IDO1AGXTMAOBCYP1A2 | |
| SCHEMBL8993038 | 0.87 | MTNR1A (0.56) | TAAR1IDO1AGXTCHRM2CHRM1 | |
| SCHEMBL1681007 | 0.87 | SMN1; SMN2 (0.60) | TAAR1IDO1AGXT | |
| SCHEMBL30028261 | 0.86 | TAAR1 (0.46) | TAAR1IDO1AGXTCHRM2CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1875 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559582-B2 | Polyacrylate polymer | BASF SE (DE) | 2026-02-24 | — | — | US | claimed |
| CN-119613256-A | Preparation method of alpha, beta-unsaturated ester | 鲁东大学 | 2025-03-14 | — | — | CN | claimed |
| US-20250075147-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NEW FLAVOR AND FRAGRANCE INGREDIENTS | OSMO LABS, PBC | 2025-03-06 | — | — | US | claimed |
| CN-119039595-A | Hyperbranched phosphate compound and preparation method and application thereof | 立邦涂料（中国）有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-118925758-A | Biomass carbon-based bifunctional catalyst, preparation method and application thereof in preparing aldehyde and acetal by oxidizing primary alcohol | 南京林业大学 | 2024-11-12 | — | — | CN | claimed |
| CN-116474744-B | Porous adsorbent and preparation method and application thereof | 荆楚理工学院 | 2024-11-05 | — | — | CN | claimed |
| CN-115369432-B | Method for preparing nitrile by electrocatalytic coupling of primary alcohol and ammonia substance | 大连理工大学 | 2024-08-20 | — | — | CN | claimed |
| CN-118112898-A | Photoresist stripping liquid and application thereof | 芝普企业股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| US-20240158370-A1 | CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDS | INNOVO THERAPEUTICS, INC. | 2024-05-16 | — | — | US | claimed |
| CN-115819221-B | Preparation method of (R) -2-hydroxymethyl propionic acid and (S) -2-hydroxymethyl propionic acid | 上海馨远医药科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| EP-0674232-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0659195-A1 | ETHYLENIC OXYGEN SCAVENGING COMPOSITIONS AND PROCESS FOR MAKING SAME BY ESTERIFICATION OR TRANSESTERIFICATION IN A REACTIVE EXTRUDER | CHEVRON U.S.A. INC. (US) | 1995-06-28 | — | — | EP | claimed |
| WO-1995002616-A9 | ETHYLENIC OXYGEN SCAVENGING COMPOSITIONS AND PROCESS FOR MAKING SAME BY ESTERIFICATION OR TRANSESTERIFICATION IN A REACTIVE EXTRUDER | — | 1995-04-27 | — | — | WO | claimed |
| WO-1995002616-A2 | ETHYLENIC OXYGEN SCAVENGING COMPOSITIONS AND PROCESS FOR MAKING SAME BY ESTERIFICATION OR TRANSESTERIFICATION IN A REACTIVE EXTRUDER | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1995-01-26 | — | — | WO | claimed |
| US-5336811-A | Reacting corresponding aryl methanol with a free radical nitroxide in the presence of a nitrogen oxide generating compound | SHELL OIL COMPANY (US) | 1994-08-09 | — | — | US | claimed |
| EP-0390480-B1 | Developer composition for PS plates for use in making lithographic printing plate and method of platemaking | FUJI PHOTO FILM CO LTD (JP) | 1994-06-01 | — | — | EP | claimed |
| US-5149614-A | DEVELOPER COMPOSITIONS FOR PS PLATES AND METHOD FOR DEVELOPING THE SAME WHEREIN THE DEVELOPER COMPOSITION CONTAINS A SURFACTANT HAVING AN ARYL GROUP, AN OXYALKYLENE GROUP AND A SULFATE ESTER OR SULFONIC ACID GROUP | FUJI PHOTO FILM CO., LTD. (JP) | 1992-09-22 | — | — | US | claimed |
| US-5126229-A | No background contamination | FUJI PHOTO FILM CO., LTD. (JP) | 1992-06-30 | — | — | US | claimed |
| US-5043252-A | Phenolic alcohols | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-27 | — | — | US | claimed |
| US-4647666-A | Heterocyclic synthesis via thallation and subsequent palladium-promoted olefination | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1987-03-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559582-B2 | Polyacrylate polymer | SAAL1, ATXN2L, VCL | TAAR1 1915/4885IDO1 2092/4885AGXT 316/4885 |
| US-20240158370-A1 | CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDS | CKS1B, CKS2, MARK1 | TAAR1 3944/4885IDO1 1901/4885AGXT 1556/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.